China · Delayed Price · Currency is CNY Xiangyu Medical Co.,Ltd Statistics
Total Valuation
SHA:688626 has a market cap or net worth of CNY 5.77 billion. The enterprise value is 5.46 billion.
| Market Cap | 5.77B |
| Enterprise Value | 5.46B |
Important Dates
The last earnings date was Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
SHA:688626 has 156.07 million shares outstanding. The number of shares has decreased by -1.10% in one year.
| Current Share Class | 156.07M |
| Shares Outstanding | 156.07M |
| Shares Change (YoY) | -1.10% |
| Shares Change (QoQ) | -7.25% |
| Owned by Insiders (%) | 5.94% |
| Owned by Institutions (%) | 5.98% |
| Float | 50.75M |
Valuation Ratios
The trailing PE ratio is 68.44 and the forward PE ratio is 57.77.
| PE Ratio | 68.44 |
| Forward PE | 57.77 |
| PS Ratio | 7.38 |
| PB Ratio | 2.73 |
| P/TBV Ratio | 3.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 31.96 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 66.20 |
| EV / Sales | 6.98 |
| EV / EBITDA | 46.27 |
| EV / EBIT | 92.76 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.60 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 4.87 |
| Debt / FCF | -18.92 |
| Interest Coverage | 49.75 |
Financial Efficiency
Return on equity (ROE) is 3.99% and return on invested capital (ROIC) is 3.14%.
| Return on Equity (ROE) | 3.99% |
| Return on Assets (ROA) | 1.13% |
| Return on Invested Capital (ROIC) | 3.14% |
| Return on Capital Employed (ROCE) | 2.46% |
| Weighted Average Cost of Capital (WACC) | 5.99% |
| Revenue Per Employee | 356,204 |
| Profits Per Employee | 37,548 |
| Employee Count | 2,195 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.86 |
Taxes
| Income Tax | -3.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.71% in the last 52 weeks. The beta is 0.42, so SHA:688626's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -32.71% |
| 50-Day Moving Average | 43.55 |
| 200-Day Moving Average | 55.08 |
| Relative Strength Index (RSI) | 29.69 |
| Average Volume (20 Days) | 1,714,522 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688626 had revenue of CNY 781.87 million and earned 82.42 million in profits. Earnings per share was 0.54.
| Revenue | 781.87M |
| Gross Profit | 513.48M |
| Operating Income | 58.82M |
| Pretax Income | 78.73M |
| Net Income | 82.42M |
| EBITDA | 113.02M |
| EBIT | 58.82M |
| Earnings Per Share (EPS) | 0.54 |
Balance Sheet
The company has 899.35 million in cash and 574.78 million in debt, with a net cash position of 324.57 million or 2.08 per share.
| Cash & Cash Equivalents | 899.35M |
| Total Debt | 574.78M |
| Net Cash | 324.57M |
| Net Cash Per Share | 2.08 |
| Equity (Book Value) | 2.11B |
| Book Value Per Share | 14.31 |
| Working Capital | 544.82M |
Cash Flow
In the last 12 months, operating cash flow was 180.56 million and capital expenditures -210.95 million, giving a free cash flow of -30.39 million.
| Operating Cash Flow | 180.56M |
| Capital Expenditures | -210.95M |
| Depreciation & Amortization | 54.19M |
| Net Borrowing | 213.67M |
| Free Cash Flow | -30.39M |
| FCF Per Share | -0.19 |
Margins
Gross margin is 65.67%, with operating and profit margins of 7.52% and 10.54%.
| Gross Margin | 65.67% |
| Operating Margin | 7.52% |
| Pretax Margin | 10.07% |
| Profit Margin | 10.54% |
| EBITDA Margin | 14.45% |
| EBIT Margin | 7.52% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | -25.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.64% |
| Buyback Yield | 1.10% |
| Shareholder Yield | 1.54% |
| Earnings Yield | 1.43% |
| FCF Yield | -0.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |